
Home Chapter Home Jobs Conferences Fellowships Books
Advertisement
Breast-nonmalignant
Atypical hyperplasia
Atypical lobular hyperplasia (ALH) of breast
Reviewer: Hind Nassar, M.D. in January 2009 (see Authors page)
Revised: 25 March 2010, last major update March 2010
Copyright: (c) 2002-2010, PathologyOutlines.com, Inc.
Definition
=========================================================================
● Part of spectrum of lobular neoplasia, which also includes LCIS (see Breast-malignant chapter)
Terminology
=========================================================================
● Also called lobular intraepithelial neoplasia 1 (LIN1) and occasionally flat epithelial atypia (although this is a separate topic, click here)
Epidemiology
=========================================================================
●
Sites
=========================================================================
●
Etiology
=========================================================================
●
Clinical features
=========================================================================
● Usually not associated with specific mammographic findings
● Does not form a palpable mass
● 19% develop invasive cancer at mean 15 years after diagnosis (4-5x usual risk), 42% are special subtypes with good prognosis (Cancer 2006;107:1227)
Prognostic factors
=========================================================================
● 4-5x usual risk of carcinoma, higher in ipsilateral breast, higher if age < 50 years (Am J Surg Pathol 2002;26:421, Cancer 2007;109:180); risk increased further if ductal involvement (Hum Path 1988;19:201)
If present at core biopsy, is surgical excision appropriate?
Many studies support excision due to risk of subsequent in situ or invasive carcinoma
● Yes: DCIS/invasive carcinoma occurs in 6-8% (Archives 2008;132:979, Am J Surg Pathol 2007;31:717), invasive ductal/lobular carcinoma occurs in 25% (Am J Surg Pathol 2005;29:534, AJR Am J Roentgenol 2008;190:637)
● No, unless: radiologic-pathologic discordance suggests that the targeted lesion was not excised, other high risk lesions such as ADH are present that would warrant further surgery, ALH has features resembling DCIS (Am J Surg Pathol 2002;26:1095), ALH has pleomorphic features (Mod Pathol 2008;21:1208, Cancer 2008;112:2152), or there is diffuse lobular neoplasia at core biopsy (Breast J 2007;13:55)
● No: because there is no significantly increased risk and any subsequent cancer is diffuse, bilateral and not at location of biopsy (Am J Surg 2009;198:792)
Case reports
=========================================================================
●
Treatment
=========================================================================
● Life long follow up is recommended
Clinical images
=========================================================================
●
Gross description (Macroscopy)
=========================================================================
● Usually an incidental finding, not a palpable mass
Gross images
=========================================================================
Micro description (Histopathology)
=========================================================================
● Resembles LCIS but does not fill or distend 50% or more acini within a lobule (i.e. some features of LCIS but not uniformly present throughout entire lobule)
● May be no/minimal inflammatory response
Micro images
=========================================================================
Atypical cells with focal preservation of luminal spaces
Pagetoid ductal involvement
Involving sclerosing adenosis
AFIP Images (Figure number is in URL)
AFIP - Focal preservation of luminal spaces Neoplastic cells occupy <50% of acini
Loss of cell cohesion, disorderly spread and Haphazardly dispersed atypical cells
pagetoid involvement into normal acini (arrows) have partially replaced normal
(but <50% of acini involved) lobular cells
Expansion of acini on left side Tumor cells with loss of cohesion have
almost entirely filled lumina
Clover-leaf pattern of proliferation around Ill defined glandular proliferation
terminal duct with preservation of normal around terminal duct
epithelium centrally
ALH - various images
ALH in fibroadenoma
ALH and LCIS
Microglandular adenosis with adjacent ALH Tubular adenoma with ALH
E-cadherin is focally negative
Virtual Slides
=========================================================================
ALH and ADH involving a fibroadenoma ALH and focal LCIS
ALH involving sclerosing adenosis
Videos
=========================================================================
Cytology description
=========================================================================
● Loosely cohesive cell clusters composed of uniform cells with occasional intracytoplasmic lumina, minimal nuclear atypia but frequent eccentric nuclei
Cytology images
=========================================================================
●
Positive stains
=========================================================================
● ER (ER alpha stronger than ER beta, Virchows Arch 2007;451:893)
● CK 34betaE12 (polarized)
● p120catenin (cytoplasmic, not membranous staining, Am J Surg Pathol 2007;31:427)
● Also ER, PR
Negative stains
=========================================================================
● E-cadherin (Mod Path 2005;18:741), HER2
Electron microscopy descriptions
=========================================================================
● Intracytoplasmic lumina, microvilli with secretory droplets; basement membrane and myoepithelial cells are present
Electron microscopy images
=========================================================================
Molecular / cytogenetics description
=========================================================================
● Diploid
Molecular / cytogenetics images
=========================================================================
Differential Diagnosis
=========================================================================
● Solid ductal intraepithelial neoplasias: usually cohesive cells with multiple secondary lumina, rosette-like nuclei, E-cadherin+
Additional references
=========================================================================
End of Breast-nonmalignant > Atypical hyperplasia > Atypical lobular hyperplasia (ALH) of breast
This information is intended for physicians and related personnel, who understand that medical information is often imperfect, and must also be interpreted in the context of a patient's clinical data using reasonable medical judgment. This website should not be used as a substitute for the advice of a licensed physician.
All information on this website is protected by copyright of PathologyOutlines.com, Inc. Information from third parties may also be protected by copyright. Please contact us at copyrightPathOut@gmail.com with any questions (click here for other contact information).